US8753870B2 - Device for detecting and separating target molecules and method for detecting and separating target molecules by using the same - Google Patents
Device for detecting and separating target molecules and method for detecting and separating target molecules by using the same Download PDFInfo
- Publication number
- US8753870B2 US8753870B2 US13/605,787 US201213605787A US8753870B2 US 8753870 B2 US8753870 B2 US 8753870B2 US 201213605787 A US201213605787 A US 201213605787A US 8753870 B2 US8753870 B2 US 8753870B2
- Authority
- US
- United States
- Prior art keywords
- target molecule
- linked
- target
- separation portion
- signal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 28
- 238000000926 separation method Methods 0.000 claims abstract description 95
- 238000004519 manufacturing process Methods 0.000 claims abstract description 38
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 36
- 210000004027 cell Anatomy 0.000 claims description 32
- 239000007787 solid Substances 0.000 claims description 26
- 108020004707 nucleic acids Proteins 0.000 claims description 23
- 102000039446 nucleic acids Human genes 0.000 claims description 23
- 238000003776 cleavage reaction Methods 0.000 claims description 22
- 150000007523 nucleic acids Chemical class 0.000 claims description 22
- 230000007017 scission Effects 0.000 claims description 22
- 108010090804 Streptavidin Proteins 0.000 claims description 19
- 229960002685 biotin Drugs 0.000 claims description 18
- 235000020958 biotin Nutrition 0.000 claims description 18
- 239000011616 biotin Substances 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 17
- 239000000427 antigen Substances 0.000 claims description 14
- 108091007433 antigens Proteins 0.000 claims description 14
- 102000036639 antigens Human genes 0.000 claims description 14
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 239000011324 bead Substances 0.000 claims description 9
- 239000011521 glass Substances 0.000 claims description 7
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 5
- 230000000295 complement effect Effects 0.000 claims description 5
- 239000010949 copper Substances 0.000 claims description 5
- 239000010931 gold Substances 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 108091023037 Aptamer Proteins 0.000 claims description 3
- 102000016911 Deoxyribonucleases Human genes 0.000 claims description 3
- 108010053770 Deoxyribonucleases Proteins 0.000 claims description 3
- 238000001069 Raman spectroscopy Methods 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 229910052737 gold Inorganic materials 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 239000002096 quantum dot Substances 0.000 claims description 2
- 239000004332 silver Substances 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims 3
- 238000001514 detection method Methods 0.000 abstract description 8
- 210000004881 tumor cell Anatomy 0.000 description 9
- 238000003556 assay Methods 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 5
- 206010006187 Breast cancer Diseases 0.000 description 4
- 208000026310 Breast neoplasm Diseases 0.000 description 4
- 108020004682 Single-Stranded DNA Proteins 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 3
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 2
- -1 Q-dot Substances 0.000 description 2
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 2
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000002094 self assembled monolayer Substances 0.000 description 2
- 239000013545 self-assembled monolayer Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000252506 Characiformes Species 0.000 description 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 238000007885 magnetic separation Methods 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000010944 silver (metal) Substances 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5302—Apparatus specially adapted for immunological test procedures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
Definitions
- separating tumor cells from the blood and detecting a protein expressed from tumor cells are very important in diagnosis and treatment.
- Particular cells may be separated from a sample by using a magnetic separation method using a magnetic field, a three-dimensional filler method using a maximized binding surface area, a filter method using a size difference, etc.
- Tumor cells are present in a very small amount in the blood, and according to their kinds, the kind or amount of protein expressed on their surfaces may vary. Accordingly, existing methods have limitations.
- cells need to be separated intact under mild conditions.
- additional assays such as genetic variations, cytoplasm experiments, or culture experiments, which follow the separation and detection of the tumor cells.
- devices and systems for efficiently detecting or separating a small amount of target molecules or target cells included in a sample and detection and separation methods using the devices or systems.
- a device or system for detecting or separating target molecules wherein the device or system includes: a target molecule linkage portion that is specifically linkable to target molecules; a signal production portion that is linked to the target molecule linkage portion and produces a detectable signal; a first separation portion linked to the signal production portion; and a second separation portion that is fixed on a solid support and is specifically linkable to the first separation portion, wherein the first separation portion and the second separation portion have a cleavage region when linked to each other.
- the method includes providing a sample including target molecules; introducing the sample to a device that includes a target molecule linkage portion that is specifically linkable to the target molecules, a signal production portion that is linked to the target molecule linkage portion and produces a detectable signal, a first separation portion linked to the signal production portion, and a second separation portion that is fixed on a solid support and is specifically linkable to the first separation portion, wherein the first separation portion and the second separation portion have a cleavage region when linked to each other; linking the target molecules and the target molecule linkage portion, followed by detecting a detection signal produced from the signal production portion; linking the first separation portion and the second separation portion, followed by washing to remove a non-linked material to separate the target molecules from the sample; and cleaving the cleavage region of the first and second separation portions, followed by collecting the result cleaved portion to separate the target molecules from the solid support.
- the target molecules may include a protein present on surfaces of target cells.
- the target cells may include a circulating tumor cell (CTC).
- CTC circulating tumor cell
- the target molecule linkage portion may include an antibody, polypeptide, or aptamer, which are specifically linkable to the target molecule.
- Molecules, compounds, and other materials are specifically linkable with a binding partner if they bind to the binding partner with greater affinity as compared to other non-binding partner molecules, compounds, or materials. In other words, they discriminately or specifically bind their binding partners.
- the signal production portion may be selected from the group consisting of dye, dye-labeled glass beads, dye-labeled polymer beads, Q-dot, Au, Ag, Cu, silica, and magnetic beads.
- the detectable signal may be selected from the group consisting of a fluorescent signal, a luminescent signal, a color signal, a Raman signal, and a surface-enhanced Raman scattering (SERS) signal.
- the first separation portion and the second separation portion may respectively be a single-stranded nucleic acid, and a single-stranded nucleic acid that is complementary thereto; biotin, and a structure including streptavidin that specifically binds to the biotin and a double-stranded nucleic acid linked to the streptavidin; streptavidin, and a structure including biotin that specifically binds to the streptavidin and a double-stranded nucleic acid linked to the biotin; a material that is the same material as a target molecule linkage portion, and a structure including a material that is the same material as a target molecule and a double-stranded nucleic acid linked to the material; or a first antibody or antigen, and a structure including a second antibody or antigen that specifically binds to the first antibody or antigen and a double-stranded nucleic acid linked to the second antibody or antigen.
- a double-stranded nucleic acid region formed when the first separation portion is linked to the second separation portion may include a region that is cleavable by a cleavage enzyme.
- the cleavage enzyme may be selected from the group consisting of DNase, EcoRI, BamHI, HindIII, Kpn I, Not I, Pst I, Sma I, and Alu I.
- FIG. 1 is a conceptual diagram of a device or system for detecting or separating a target molecule, according to an embodiment of the present invention, illustrating elements of the device;
- FIG. 2 illustrates examples of constituting elements of a device or system for detecting or separating a target molecule, according to an embodiment of the present invention
- FIG. 3 shows images for confirming a linkage between a device or system for detecting or separating target molecules, according to an embodiment of the present invention, and target molecules (MCF-7 cells), wherein an amount of a material used as a target molecule linkage portion varies;
- FIGS. 4A to 4C show images illustrating a method of detecting or separating target molecules by using a device or system for detecting or separating target molecules, according to an embodiment of the present invention, and separation results;
- FIGS. 5A to 5C show images illustrating a method of detecting or separating target molecules by using a device or system for detecting or separating target molecules, according to another embodiment of the present invention, and separation results.
- FIG. 1 is a conceptual diagram of a device or system for detecting or separating a target molecule 10 , according to an embodiment of the present invention.
- the device or system according to the present embodiment includes a target molecule linkage portion 100 that is specifically linkable to the target molecule 10 ; a signal production portion 200 that is linked to the target molecule linkage portion 100 and produces a detectable signal; a first separation portion 300 linked to the signal production portion 200 ; and a second separation portion 400 that is fixed on a solid support 500 and is specifically linkable to the first separation portion 300 , wherein the first separation portion 300 and the second separation portion 400 have a cleavage region when they are linked.
- the device or system is for detecting or separating target molecules present inside a sample.
- the target molecules may include a biomolecular material, such as protein, nucleic acid, cells, organelles, bacteria, and viruses, but is not limited thereto.
- the target molecule 10 may be a protein present on the surface of a target cell 1 .
- the target cell 1 may be a circulating tumor cell (CTC).
- CTC circulating tumor cell
- a breast tumor cell which is a kind of CTC, may have a subtype (Normal-like, Basal-like, Luminal, HER2-Positive) that is determined according to a protein expressed on the surface of a cell, such as ER, PR, HER2, CK5/6 etc.
- the kind or amount of the protein on the surface of a cell may significantly vary according to the subtype. Accordingly, separating and detecting breast tumor cells included in a blood sample may be efficiently performed using a particular protein that expresses on surfaces of the breast tumor cells as target molecules.
- the device or system includes a target molecule linkage portion 100 , which is specifically linked or bound to the target molecule 10 so as to be able to detect specifically and distinguish the target molecule 10 included in a sample from other molecules or compounds that may be in the sample.
- the target molecule linkage portion 100 may be an antibody that is specific to (specifically linkable to) the antigen.
- the target molecule linkage portion 100 may be antibody, polypeptide, or aptamer, which are specifically linkable to the target molecule 10 , for example, a protein expressed on the surface of a cell.
- the target molecule linkage portion 100 may not be limited as long as the target molecule linkage portion 100 is specifically linkable to any target molecule.
- the term antibody encompasses antibody fragments (e.g., Fab, ScFv, single domain, etc.).
- the device or system includes the signal production portion 200 connected to the target molecule linkage portion 100 .
- the signal production portion 200 is used to confirm whether the target molecule 10 included in a sample is specifically linked to the target molecule linkage portion 100 , and may not be limited as long as the signal production portion 200 produces a detectable signal.
- the detectable signal may be a fluorescent signal, a luminescent signal, a color signal, a Raman signal, or a surface-enhanced Raman scattering (SERS) signal, but is not limited thereto.
- the signal production portion 200 may be dye, dye-labeled glass beads, dye-labeled polymer beads, Quantum dot (Q-dot), gold (Au) particles, silver (Ag) particles, copper (Cu) particles, silica, or magnetic beads.
- Q-dot Quantum dot
- Au gold
- Ag silver
- Cu copper
- silica silica
- the linkage between the target molecule linkage portion 100 and the signal production portion 200 may be easily embodied by one of ordinary skill in the art through any known method, such as complementary binding between streptavidin and biotin.
- the device or system may include the first separation portion 300 and the second separation portion 400 to perform an additional assay after the target molecule 10 included in a sample is detected.
- the additional assay may include separation of the target molecule 10 , a polymerization enzyme chain reaction (PCR) of the target molecule 10 , cell culture, etc.
- the first separation portion 300 may be linked to the signal production portion 200
- the second separation portion 400 may be fixed on the solid support 500
- the first separation portion 300 may be mutually specifically linked to the second separation portion 400
- each of the first separation portion 300 and the second separation portion 400 includes a cleavage region when in a linked state.
- the solid support 500 may be glass, silicon, synthetic resin, or the like, but is not limited thereto.
- the linkage between the signal production portion 200 and the first separation portion 300 may be easily embodied by one of ordinary skill in the art through any known method, such as complementary binding between streptavidin and biotin.
- the fixing of the second separation portion 400 on the solid support 500 may be easily embodied by one of ordinary skill in the art through any known method, such as a self-assembled monolayer (SAM) coating method and an amine nucleic acid fixation method.
- SAM self-assembled monolayer
- FIG. 2 illustrates examples of elements of a device or system for detecting or separating a target molecule 10 , according to an embodiment of the present invention.
- the device or system according to the present embodiment includes a target molecule linkage portion 100 that is linkable to the target molecule 10 expressed on the surface of a target cell 1 , a signal production portion 200 linked to the target molecule linkage portion 100 , a first separation portion 300 linked to the signal production portion 200 , and a second separation portion 400 that is linked to a solid support 500 . Also, referring to FIG.
- the first separation portion 300 and the second separation portion 400 may respectively be a single-stranded nucleic acid and a single-stranded nucleic acid that is complementary thereto; biotin, and a structure including streptavidin that specifically binds to the biotin and a double-stranded nucleic acid linked to the streptavidin; streptavidin, and a structure including biotin that specifically binds to the streptavidin and a double-stranded nucleic acid linked to the biotin; a material that is the same material as a target molecule linkage portion, and a structure including a material that is the same material as a target molecule and a double-stranded nucleic acid linked to the material; or a first antibody or antigen and a structure including a second antibody or antigen that specifically binds to the first antibody or antigen and a double-stranded nucleic acid linked to the second antibody or antigen, but is not limited thereto.
- the cleavage region may be a double-stranded nucleic acid region formed when the first separation portion 300 is linked to the second separation portion 400 and may be cleavable by a cleavage enzyme, but is not limited thereto.
- the cleavage enzyme may be DNase, EcoRI, BamHI, HindIII, Kpn I, Not I, Pst I, Sma I, or Alu I.
- a method of detecting or separating the target molecule 10 by using a device or system includes providing a sample including the target molecule 10 ; and introducing the sample to the device or system that includes the target molecule linkage portion 100 that is specifically linkable to the target molecule 10 ; the signal production portion 200 that is linked to the target molecule linkage portion 100 and produces a detectable signal; the first separation portion 300 linked to the signal production portion 200 ; and the second separation portion 400 that is fixed on the solid support 500 and is specifically linkable to the first separation portion 300 , wherein the first separation portion 300 and the second separation portion 400 have a cleavage region when they are linked.
- the sample may include, in addition to the target molecule 10 , non-target molecules.
- the method includes linking the target molecule 10 and the target molecule linkage portion 100 , followed by linking the first separation portion 300 and the second separation portion 400 ; detecting a detectable signal produced from the signal production portion 200 after the linking; washing to remove a non-linked molecule after the linking; and separating cleaved portions after the cleaving.
- the target molecule 10 may be qualitatively or quantitatively assayed using a signal produced from the signal production portion 200 , and also, may be isolated by removing non-target molecules from the sample.
- the cleavage region of the first and second separation portions 300 and 400 is cleaved, and the resultant cleaved portion is collected to separate the target molecule 10 from the solid support 500 .
- the target molecule 10 included in the cleaved portion is separated from the solid support 500 under mild conditions, thereby enabling additional assays of the target molecule 10 .
- the detection and separation thereof may be easily performed. Furthermore, the target molecules 10 are separated from the solid support 500 under mild conditions, thereby enabling additional assays easily.
- MCF-7 cells which are a kind of breast tumor cell, were used as target molecules.
- a biotinylated anti-EpCAM antibody was prepared as a target molecule linkage portion that is specifically linkable to the MCF-7 cells, streptavidin-coated Q-dot was prepared as a signal production portion, and a single-stranded DNA (5′-TGTCCAAGCTTACAAGCTTACT-3′) to which biotin was linked was used as a first separation portion.
- biotinylated anti-EpCAM antibody The biotinylated anti-EpCAM antibody, the streptavidin-coated Q-dot and biotin-linked single-stranded DNA were reacted at room temperature for about 1 hour, followed by centrifugal filtration, to prepare a first complex of target molecule linkage portion-signal production portion-first separation portion.
- a slide glass was used as a solid support, and the slide glass was treated with a Piranha solution, and 3-aminopropyltriethoxysilane (APTES) was coated thereon, followed by treatment of succinic anhydride.
- APTES 3-aminopropyltriethoxysilane
- the slide glass with a carboxylic acid surface was prepared.
- amine linked single-stranded DNA 5′-ATGATAGGAGTAAGCTTGTAAGCTTGG-3′ was used, and the second separation portion was linked to the carboxylic acid surface by EDC/NHS, thereby preparing a solid support on which the second separation portion was fixed.
- FIG. 3 shows images for confirming a linkage between a device for detecting or separating target molecules, according to an embodiment of the present invention, and target molecules (MCF-7 cells), wherein an amount of a material used as a target molecule linkage portion varies.
- the amount of the target molecule linkage portion was 1 pmol in Condition 1; 2 pmol in Condition 2; 5 pmol in Condition 3; 10 pmol in Condition 4; and 5 pmol in Condition 5.
- the linkage was more clearly confirmed in Conditions 4 and 5.
- FIGS. 4A to 4C show images illustrating a method of detecting or separating target molecules by using a device for detecting or separating target molecules, according to an embodiment of the present invention, and separation results.
- FIG. 4A is a schematic view illustrating a process of detecting or separating MCF-7 cells
- FIGS. 4B and 4C show images of the result of each step of the process.
- the complex 1 of target molecule linkage portion 100 -signal production portion 200 -first separation portion 300 prepared according to Example 1 was introduced to a solid support on which the second separation portion 400 was fixed, and MCF-7 cells were linked thereto. Then, the first separation portion 300 was linked to the second separation portion 400 , followed by washing the solid support with 2 ⁇ SSPE buffer. Then, a signal produced from the signal production portion 200 was measured (see illustrations on the left side of the arrow on FIG. 4A , and the image of FIG. 4B ).
- the cleavage region of the first and second separation portions 300 and 400 linked to each other was cleaved with HindIII as a cleavage enzyme to collect a cleaved region (including MCF-7 cells), and the state of the solid support was confirmed (see the illustration on the right side of the arrow on FIG. 4A , and FIG. 4C ).
- FIG. 4B it was confirmed that MCF-7 cells were detected and separated, and referring to FIG. 4C , it was confirmed that MCF-7 cells were removed from the solid support.
- FIGS. 5A to 5C show images illustrating a method of detecting or separating target molecules by using a device for detecting or separating target molecules, according to another embodiment of the present invention, and separation results thereby.
- FIG. 5A is a schematic view illustrating a process of detecting or separating MCF-7 cells
- FIGS. 5B and 5C show images of the result of each step of the process.
- a device for detecting or separating target molecules used in this experiment was the same as the device used in Example 2, except that streptavidin was used as the first separation portion 300 in the complex 1 of target molecule linkage portion 100 -signal production portion 200 -first separation portion 300 , a double-stranded DNA linked to biotin that is binding specifically to the streptavidin was used as the second separation portion 400 , and a microchannel was used as a solid support.
- the complex 1 of target molecule linkage portion 100 -signal production portion 200 -first separation portion 300 was introduced to a solid support on which the second separation portion 400 was fixed, and MCF-7 cells were linked thereto. Then, the first separation portion 300 was linked to the second separation portion 400 , followed by washing the solid support with 2 ⁇ SSPE buffer. Then, a signal produced from the signal production portion 200 was measured (see illustrations on the left side of the arrow on FIG. 5A , and the image of FIG. 5B ).
- the cleavage region of the first separation portion 300 and second separation portions 400 linked to each other was cleaved by HindIII as a cleavage enzyme to collect a cleaved region (including MCF-7 cells), and the state of the solid support was confirmed (see the illustration on the right side of the arrow on FIG. 5A , and FIG. 5C ).
- FIG. 5B it was confirmed that MCF-7 cells were detected and separated, and referring to FIG. 5C , it was confirmed that MCF-7 cells were removed from the solid support.
- a small amount of target molecules or target cells included in a sample may be efficiently detected or separated from a sample.
Abstract
Description
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110126281A KR101933618B1 (en) | 2011-11-29 | 2011-11-29 | Device for detecting and separating target biomolecules and method for detecting and separating target biomolecules using the same |
KR10-2011-0126281 | 2011-11-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
US20130137092A1 US20130137092A1 (en) | 2013-05-30 |
US8753870B2 true US8753870B2 (en) | 2014-06-17 |
Family
ID=48467206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/605,787 Expired - Fee Related US8753870B2 (en) | 2011-11-29 | 2012-09-06 | Device for detecting and separating target molecules and method for detecting and separating target molecules by using the same |
Country Status (2)
Country | Link |
---|---|
US (1) | US8753870B2 (en) |
KR (1) | KR101933618B1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017007271A1 (en) * | 2015-07-09 | 2017-01-12 | 주식회사 넥스모스 | Aptamer-coated microneedle-based diagnostic skin patch |
CN109100511B (en) * | 2018-07-20 | 2019-09-24 | 四川大学 | Capture and the immune magnetic nano particle of release and preparation method thereof are visualized for circulating tumor cell |
CN110412014A (en) * | 2019-08-28 | 2019-11-05 | 济南大学 | Application of the Surface enhanced Raman scattering paper base sensor in tumor-marker analyte detection |
KR102346111B1 (en) * | 2020-02-07 | 2022-01-03 | 주식회사 싸이토딕스 | Magnetic bead for ctc separation and ctc separation method using the same |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030054376A1 (en) * | 1997-07-07 | 2003-03-20 | Mullis Kary Banks | Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus |
US6962786B2 (en) | 1996-07-29 | 2005-11-08 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US20060046313A1 (en) | 2004-08-26 | 2006-03-02 | Intel Corporation | Cellular analysis using Raman surface scanning |
US20070026381A1 (en) | 2005-04-05 | 2007-02-01 | Huang Lotien R | Devices and methods for enrichment and alteration of cells and other particles |
US7323309B2 (en) | 2000-03-28 | 2008-01-29 | Northwestern University | Bio-barcodes based on oligonucleotide-modified particles |
US20090188864A1 (en) | 2008-01-29 | 2009-07-30 | Siyang Zheng | Method and apparatus for microfiltration to perform cell separation |
US7829350B2 (en) | 2001-06-06 | 2010-11-09 | The General Hospital Corporation | Magnetic-nanoparticle conjugates and methods of use |
US20100285581A1 (en) | 2007-09-17 | 2010-11-11 | Adnagen Ag | Solid Phase Cell Isolation and/or Enrichment Method |
US20110104718A1 (en) | 2001-08-23 | 2011-05-05 | Veridex, Llc | Analysis of Circulating Tumor Cells, Fragments, and Debris |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101313217A (en) | 2005-11-25 | 2008-11-26 | 皇家飞利浦电子股份有限公司 | Sensitive magnetic catch assay by building a strong binding couple |
US8071395B2 (en) * | 2007-12-12 | 2011-12-06 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and apparatus for magnetic separation of cells |
-
2011
- 2011-11-29 KR KR1020110126281A patent/KR101933618B1/en active IP Right Grant
-
2012
- 2012-09-06 US US13/605,787 patent/US8753870B2/en not_active Expired - Fee Related
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6962786B2 (en) | 1996-07-29 | 2005-11-08 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US20030054376A1 (en) * | 1997-07-07 | 2003-03-20 | Mullis Kary Banks | Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus |
US7323309B2 (en) | 2000-03-28 | 2008-01-29 | Northwestern University | Bio-barcodes based on oligonucleotide-modified particles |
US7829350B2 (en) | 2001-06-06 | 2010-11-09 | The General Hospital Corporation | Magnetic-nanoparticle conjugates and methods of use |
US20110104718A1 (en) | 2001-08-23 | 2011-05-05 | Veridex, Llc | Analysis of Circulating Tumor Cells, Fragments, and Debris |
US20060046313A1 (en) | 2004-08-26 | 2006-03-02 | Intel Corporation | Cellular analysis using Raman surface scanning |
US7776547B2 (en) | 2004-08-26 | 2010-08-17 | Intel Corporation | Cellular analysis using Raman surface scanning |
US20070026381A1 (en) | 2005-04-05 | 2007-02-01 | Huang Lotien R | Devices and methods for enrichment and alteration of cells and other particles |
US20100285581A1 (en) | 2007-09-17 | 2010-11-11 | Adnagen Ag | Solid Phase Cell Isolation and/or Enrichment Method |
US20090188864A1 (en) | 2008-01-29 | 2009-07-30 | Siyang Zheng | Method and apparatus for microfiltration to perform cell separation |
Non-Patent Citations (2)
Title |
---|
Ho et al, DNA as a Force Sensor in an Aptamer-Based Biochip for Adenosine, 2009, Ananl. Chem., 81, 3159-3164. * |
Sieuwerts et al, "Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells", J. Natl Cancer Inst., 101:61-66 (2009). |
Also Published As
Publication number | Publication date |
---|---|
US20130137092A1 (en) | 2013-05-30 |
KR20130060009A (en) | 2013-06-07 |
KR101933618B1 (en) | 2018-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6996502B2 (en) | Target molecule detection method | |
EP3291916B1 (en) | Particle based immunoassay with alternating current electrokinetics | |
CN109863391A (en) | Device and method for sample analysis | |
US8753870B2 (en) | Device for detecting and separating target molecules and method for detecting and separating target molecules by using the same | |
US20080085508A1 (en) | Non-nucleic acid based biobarcode assay for detection of biological materials | |
JP2004527732A (en) | Method | |
WO2019098301A1 (en) | Target molecule detection method | |
CA3223257A1 (en) | Spatial analysis of a planar biological sample | |
EP2189539B2 (en) | Conjugate complexes for analyte detection | |
Yoshino et al. | Bioengineering of bacterial magnetic particles and their applications in biotechnology | |
JP2022519108A (en) | Equipment for manufacturing exosome liquid biopsy sample, manufacturing method, and analysis method for exosome liquid biopsy sample manufactured from it. | |
US11789014B2 (en) | Method of determining the presence or absence of a target analyte comprising using a reporter polynucleotide and a transmembrane pore | |
Lee et al. | Immunostaining extracellular vesicles based on an aqueous two-phase system: For analysis of tetraspanins | |
KR101090982B1 (en) | Bioanalysis using quantum dot-aptamer conjugate | |
CA2908613A1 (en) | Molecular nets on solid phases | |
US9200382B2 (en) | High-stringency screening of target-binding partners using a microfluidic device | |
Ates et al. | Comparative study on antibody immobilization strategies for efficient circulating tumor cell capture | |
US20240044894A1 (en) | Extracellular vesicle characterization systems | |
Krizkova et al. | Microchip Capillary Electrophoresis: Quantum Dots and Paramagnetic Particles for Bacteria Immunoseparation: Rapid Superparamagnetic-Beads-Based Automated Immunoseparation of Zn-Proteins from Staphylococcus aureus with Nanogram Yield | |
US10107805B2 (en) | Virus-microbead complex and use thereof | |
US20230417750A1 (en) | Single-molecule electronic multiplex nanopore immunoassays for biomarker detection | |
US20160349270A1 (en) | Flip (fluorescence immunoprecipitation) for high-throughput immunoprecipitation | |
EP4172589A1 (en) | Biological vesicles isolation and discovery methods and systems | |
US20090203149A1 (en) | Enhanced methods for gas and/or vapor phase analysis of biological assays | |
KR101512484B1 (en) | Rapid Methods for Detection of Norovirus in Food Using a Magnetic Bead and Quantum Dot |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SAMSUNG ELECTRONICS CO., LTD., KOREA, REPUBLIC OF Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LEE, HUN-JOO;LEE, JEONG-GUN;KIM, YEON-JEONG;AND OTHERS;REEL/FRAME:028997/0341 Effective date: 20120828 Owner name: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION SOGANG Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LEE, HUN-JOO;LEE, JEONG-GUN;KIM, YEON-JEONG;AND OTHERS;REEL/FRAME:028997/0341 Effective date: 20120828 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551) Year of fee payment: 4 |
|
AS | Assignment |
Owner name: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION SOGANG UNIVERSITY (IUCF-SU), KOREA, REPUBLIC OF Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SAMSUNG ELECTRONICS CO., LTD.;REEL/FRAME:056133/0453 Effective date: 20210414 |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
LAPS | Lapse for failure to pay maintenance fees |
Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20220617 |